673 related articles for article (PubMed ID: 5025460)
1. Inhibitor of human blood coagulation elicited by thrombin.
Marciniak E
J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
[No Abstract] [Full Text] [Related]
2. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
Pineo GF; Regoeczi E; Hatton MW; Brain MC
J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
[No Abstract] [Full Text] [Related]
3. Laboratory diagnosis of congenital coagulation defects.
Lowe GD; Forbes CD
Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
[No Abstract] [Full Text] [Related]
4. Prothrombin utilization in congenital coagulation deficiency states.
Owen CA; Thompson JH
Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
[No Abstract] [Full Text] [Related]
5. Cofactor of the "lupus anticoagulant".
Rivard GE; Schiffman S; Rapaport SI
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):554-63. PubMed ID: 4141516
[No Abstract] [Full Text] [Related]
6. [On the coagulation factors from V through XIII].
Yoshida K; Tagawa N
Nihon Rinsho; 1973 Apr; 31(4):755-64. PubMed ID: 4580392
[No Abstract] [Full Text] [Related]
7. The procoagulant activity of granulocytes.
Saba HI; Herion JC; Walker RI; Roberts HR
Proc Soc Exp Biol Med; 1973 Feb; 142(2):614-20. PubMed ID: 4689394
[No Abstract] [Full Text] [Related]
8. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
9. [Blood coagulation disorders caused by abnormal blood coagulation factors].
Fiedler H
Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
[No Abstract] [Full Text] [Related]
10. CLOTTING IN HEPARINISED PLASMA. II. UNDERLYING REACTIONS.
FANTL P
Aust J Exp Biol Med Sci; 1965 Feb; 43():45-64. PubMed ID: 14269280
[No Abstract] [Full Text] [Related]
11. Surgical care of patients with hereditary disorders of blood coagulation.
Shulman NR
Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
[No Abstract] [Full Text] [Related]
12. Prothrombin complex concentrates: preparation, properties, and clinical uses.
White GC; Lundblad RL; Kingdon HS
Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
[No Abstract] [Full Text] [Related]
13. An approach to the diagnosis of disorders of hemostasis.
Ratnoff OD
Mod Treat; 1968 Jan; 5(1):11-38. PubMed ID: 4873498
[No Abstract] [Full Text] [Related]
14. PLASMA PROTHROMBIN ACTIVATION IN HEMORRHAGIC DISORDERS.
PENNER JA
Am J Clin Pathol; 1964 Dec; 42():561-71. PubMed ID: 14239431
[No Abstract] [Full Text] [Related]
15. Stimulation of human leukocyte thromboplastic activity by endotoxin.
Lerner RG; Goldstein R; Cummings G; Lange K
Proc Soc Exp Biol Med; 1971 Oct; 138(1):145-8. PubMed ID: 4942184
[No Abstract] [Full Text] [Related]
16. [Some recent advances in blood coagulation research].
Sakuragawa N
Rinsho Ketsueki; 1972 Dec; 13(6):923-33. PubMed ID: 4567233
[No Abstract] [Full Text] [Related]
17. Prothrombin complex concentrates.
Penner JA
Bibl Haematol; 1977; 44():81-7. PubMed ID: 617787
[TBL] [Abstract][Full Text] [Related]
18. The chemistry of blood coagulation.
Baugh RF; Hougie C
Clin Haematol; 1979 Feb; 8(1):3-30. PubMed ID: 367664
[No Abstract] [Full Text] [Related]
19. Prothrombin in factor X deficiency.
Malhotra OP; Carter JR
J Lab Clin Med; 1970 Jan; 75(1):120-7. PubMed ID: 5460666
[No Abstract] [Full Text] [Related]
20. BLOOD COAGULATION. VII. COAGULATION II.
DUGDALE M
Memphis Mid South Med J; 1963 Jan; 38():19-22. PubMed ID: 14087826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
